Centenial returns to profit with Rs 142.26 lakh H1 gain
Key highlights
- Centenial reported Rs 142.26 lakh first-half profit, against a Rs 5.11 lakh loss a year earlier.
- Revenue from operations rose about 12.4% to Rs 29.65 crore in the half year ended September 30, 2026.
- Net cash generated from operating activities was Rs 2.35 crore during the six-month period.
- Total liabilities declined to Rs 49.23 crore at September 30, 2026, from Rs 51.24 crore at March 31, 2026.
powered by IRIS

Centenial Surgical Suture Limited reported a Rs 142.26 lakh profit for the half year ended September 30, 2026, reversing a Rs 5.11 lakh loss a year earlier, as revenue from operations rose to Rs 29.65 crore from Rs 26.39 crore. The standalone unaudited results also recorded Rs 2.35 crore in operating cash generation.
Know Centenial Surgical Suture inside out
Results, valuation, peers and who's buying, in one view.
How did Centenial return to first-half profit?
Centenial returned to profit because total revenue of Rs 29.70 crore for the half year ended September 30, 2026 exceeded total expenses of Rs 27.80 crore, resulting in profit before tax of Rs 1.90 crore. In the half year ended September 30, 2025, total revenue was Rs 26.44 crore and expenses were Rs 26.49 crore, producing a Rs 5.11 lakh pre-tax loss.
Revenue from operations increased by Rs 3.26 crore year on year, while total expenses increased by Rs 1.30 crore. Cost of materials consumed declined to Rs 8.82 crore from Rs 9.25 crore and employee benefits expense fell to Rs 5.44 crore from Rs 5.90 crore, while other expenses rose to Rs 9.62 crore from Rs 9.08 crore.
After current tax of Rs 47.84 lakh, Centenial reported Rs 142.26 lakh profit from continuing operations, compared with a Rs 5.11 lakh loss in the prior-year half. No discontinued-operation amount or other comprehensive income item was reported, leaving total comprehensive income at Rs 142.26 lakh for the six-month period.
Centenial has one reportable business segment, Medical Devices, under Indian Accounting Standard 108, or Ind AS 108. The September 30, 2026 filing does not provide a revenue split by product, customer, geography or medical-device category, so it does not identify a specific source of the Rs 3.26 crore revenue increase.
What changed in Centenial's September-quarter results?
Centenial reported a Rs 68.75 lakh profit for the quarter ended September 30, 2026, compared with a Rs 1.20 lakh loss in the quarter ended September 30, 2025. Quarterly revenue from operations increased to Rs 14.31 crore from Rs 13.46 crore, while total expenses declined to Rs 13.42 crore from Rs 13.52 crore.
The September-quarter profit was lower than the Rs 73.51 lakh reported for the quarter ended June 30, 2026. Revenue from operations fell by Rs 1.03 crore from Rs 15.34 crore in June to Rs 14.31 crore in September, and profit before tax declined from Rs 98.23 lakh to Rs 91.87 lakh.
Material cost was Rs 4.47 crore in the September 2026 quarter, versus Rs 4.18 crore a year earlier. Employee benefits expense declined to Rs 2.70 crore from Rs 3.15 crore, finance cost fell to Rs 42.08 lakh from Rs 46.20 lakh, and other expenses increased to Rs 4.84 crore from Rs 4.44 crore.
Basic and diluted earnings per equity share were Rs 1.88 in the September 2026 quarter, against a loss per share of Rs 0.03 a year earlier. For the half year ended September 30, 2026, both measures were Rs 3.90, compared with a loss per share of Rs 0.14 in the corresponding 2025 period.
What does Centenial's September 2026 balance sheet show?
Centenial reported total assets of Rs 79.20 crore at September 30, 2026, compared with Rs 79.79 crore at March 31, 2026, while total equity rose to Rs 29.97 crore from Rs 28.55 crore. Equity share capital was unchanged at Rs 5.42 crore and other equity increased to Rs 24.55 crore from Rs 23.13 crore.
Current assets rose to Rs 60.49 crore from Rs 60.03 crore over the six-month period. Inventory declined to Rs 39.62 crore from Rs 40.65 crore, but trade receivables increased to Rs 19.90 crore from Rs 18.28 crore; cash and cash equivalents rose to Rs 23.30 lakh from Rs 20.17 lakh.
Total liabilities fell to Rs 49.23 crore at September 30, 2026 from Rs 51.24 crore at March 31, 2026. Non-current liabilities decreased to Rs 18.86 crore from Rs 19.67 crore, while current liabilities fell to Rs 30.36 crore from Rs 31.57 crore.
Current borrowings were Rs 10.63 crore at September 30, 2026, slightly below Rs 10.71 crore at the March 2026 year-end. Trade payables increased to Rs 9.15 crore from Rs 7.48 crore, whereas other current financial liabilities declined to Rs 5.29 crore from Rs 7.04 crore.
Got a follow-up? Ask IRIS
Did Centenial generate operating cash in the first half?
Centenial generated Rs 2.35 crore of net cash from operating activities in the half year ended September 30, 2026. Profit before tax was Rs 1.90 crore and operating profit before working-capital changes was Rs 4.83 crore, compared with Rs 5.44 crore for the year ended March 31, 2026.
Inventory released Rs 1.03 crore of cash during the six months, while the increase in trade receivables used Rs 1.62 crore. Trade and other payables used a further Rs 1.93 crore, resulting in cash generated from operations of Rs 2.55 crore before Rs 20 lakh of income-tax payments.
Investing activities used Rs 1.53 crore, including Rs 1.19 crore spent on fixed assets and capital work in progress. Financing activities used Rs 79.01 lakh, comprising Rs 71.05 lakh of finance cost and a Rs 7.96 lakh reduction in short-term borrowings.
The combined cash-flow movements produced a Rs 3.13 lakh increase in cash and cash equivalents during the period, taking the closing balance to Rs 23.30 lakh. The filing provides Rs 7.28 crore of operating cash generation for the full year ended March 31, 2026, rather than a comparable prior-year half-year cash-flow figure.
What has Centenial disclosed about fundraising and governance?
Centenial has not approved a fundraising issue or disclosed an amount, mode, price, timing or security for a potential capital raise. On November 12, 2026, the board approved in principle the engagement of an independent professional agency or financial advisory firm to assess financial viability, commercial feasibility, risks, regulatory implications and due-diligence requirements for available alternatives.
The board said it will consider the agency's findings and recommendations before taking any further decision on fundraising. Any subsequent decision would be subject to statutory, regulatory and shareholder approvals where required, and the November 12 announcement contained no target amount or timetable.
Centenial also recorded the resignation of whole-time director Anuradha Kashikar with effect from October 5, 2026. The audit committee reviewed the September 30, 2026 results and the board approved them on November 12, 2026.
The statutory auditor issued a limited review report dated November 12, 2026. It said nothing had come to its attention that caused it to believe the standalone unaudited results did not provide the disclosures required under Regulation 33 of the Securities and Exchange Board of India listing regulations or contained a material misstatement.
Conclusion
Centenial's half-year outcome shows a reported move from a Rs 5.11 lakh loss to a Rs 142.26 lakh profit, supported by revenue growth of Rs 3.26 crore and an expense increase of Rs 1.30 crore. The period also produced Rs 2.35 crore of operating cash flow, while total liabilities declined by Rs 2.01 crore from March 31, 2026.
The next disclosed matter to watch is the independent assessment of fundraising alternatives authorised on November 12, 2026. Centenial has said its board will review the agency's recommendations before deciding whether to proceed and, if it does, on the amount, mode, pricing, timing and securities involved.


